Royalty Pharma plc (RPRX) reports Q1 results

Royalty Pharma plc (NASDAQ: RPRX) reported Q1 results. Revenue for the quarter came in at $684 million versus the consensus estimate of $806.84 million.

For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Deutsche Bank Reiterates Buy Rating on Redcare Pharmacy NV (RDC:GR)
• Goldman Sachs Upgrades RENK Group AG (R3NK:GR) to Buy